Haemodialysis clinical trials

Explore recruiting haemodialysis clinical trials.

Recruiting haemodialysis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Haemodialysis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

INCREDIBLE: INCREmental DIalysis and diet for a Better Life Experience; Clinical relevance of an “add-on” Ketosteril supplementation on incremental haemodialysis period in incident haemodialysis patients. An exploratory randomized controlled trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Pharmacokinetics study of Cefazolin in haemodialysis (CEFAZODIAL)

France

Therapeutic use (Phase IV) EU CTIS Study details

CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparing Chlorhexidine and Ethanol ahead of cannulation for haemodialysis - A randomized crossover trial

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (CARD-AXA)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Difelikefalin in Adolescents Aged 12 to 17 Years on Haemodialysis with Moderate-to-Severe Pruritus (KOR-PED-202)

Spain, Greece, Italy, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Haemodialysis trials by city

Haemodialysis in Toronto Haemodialysis in Vancouver Haemodialysis in Montreal Haemodialysis in Calgary Haemodialysis in Edmonton Haemodialysis in Ottawa Haemodialysis in Winnipeg Haemodialysis in Quebec City Haemodialysis in Hamilton Haemodialysis in Kitchener Haemodialysis in London Haemodialysis in Halifax Haemodialysis in New York Haemodialysis in Los Angeles Haemodialysis in Chicago Haemodialysis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease